AXS26_DigitalGuide_Final pages - Flipbook - Page 23
WEDNESDAY, APRIL 29
11:00 PM - 11:40 PM
Mouton 2
The Affordability Race: Which Models Will Endure?
David Skomo, HealthDyne; Sarah Thomas, HealthDyne
12:00 PM - 1:30 PM
Encore Ballroom 4-8
Women’s Health Luncheon | Women’s Health 2030: The Market
Opportunity for Biopharmaceutical, MedTech, Consumer Health and
Digital Innovation
Sponsored by: CVS Health and Pharmaceutical Strategies Group (PSG)
Michael Annichine, Magee-Womens Research Institute and Foundation; Joanne
Armstrong, CVS Health; Jen Radin, Deloitte & Touche LLP; Jannine Versi, Elektra
Health
12:00 PM - 2:00 PM
Cristal Ballroom
Exhibits + Networking + Lunch
1:00 PM - 1:40 PM
Mouton 2
Best in Class Beats: Navigating the Clinical-to-Commercial Roadmap for
First Launches
Natalie Gerdt Lotier, NNIT; Kenny O. Rankin, Esteve US
1:00 PM - 1:40 PM
Margaux 2
Breaking Through Reimbursement Complexities to Enable
Patient Access
Joe DePinto, McKesson; Michael A. Evans, Geisinger; Navneet Majhail, HCA
Healthcare Sarah Cannon Cancer Network; Will Shrank, Aradigm Health
1:00 PM - 1:40 PM
Mouton 1
Digital Danger Zone: Cybersecurity Essentials for Pharmacy and
Healthcare Leaders
Paige Clark, Prescryptive; Brad Gallagher, Barclay Damon
1:00 PM - 1:40 PM
Lafite 2
Drug Pricing in Flux: Navigating the Policy Crossroads of 2026
Jeff Berkowitz, Real Endpoints; Lisa Edwards, Precision AQ; Greg Gregory, Precision
AQ; John Michael O’Brien, National Pharmaceutical Council
1:00 PM - 1:40 PM
Margaux 1
Efficiency is the New Innovation: Why Pharma Can’t Afford
to Go It Alone
Terry Milton, Eli Lilly; Kim Plesnarski, Syneos Health; Brian Siemak, Mannkind;
Angela Wlodar, Syneos Health
2:00 PM - 2:40 PM
Lafite 2
Bridging the Access Realization Gap: Building Integrated Capabilities
for Patient Outcomes and Brand Performance
Rick Lloyd, Range Health Advisors; Tate Rarick, AccessSync; Deitria Rutledge,
Johnson & Johnson; Derek Tancredi, AccessSync
* as of April 6, 2026
* please check the most current agenda online.
AGENDA I 23
